相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial
Manuel Taboada et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Anders Granholm et al.
INTENSIVE CARE MEDICINE (2022)
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Nicole Wolter et al.
LANCET (2022)
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
Negar Toroghi et al.
PHARMACOLOGICAL REPORTS (2022)
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
Luis Patricio Maskin et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2022)
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl et al.
LANCET MICROBE (2022)
Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19
Mahesh Ramanan et al.
JAMA NETWORK OPEN (2022)
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Oliver J. Watson et al.
LANCET INFECTIOUS DISEASES (2022)
Inhaled corticosteroids for the treatment of COVID-19
Mirko Griesel et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
Yewande E. Odeyemi et al.
CRITICAL CARE (2022)
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Oliver J. Watson et al.
LANCET INFECTIOUS DISEASES (2022)
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
Christiane Maria Prado Jeronimo et al.
CLINICAL INFECTIOUS DISEASES (2021)
Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action
Imad M. El-Kebbi et al.
WORLD JOURNAL OF DIABETES (2021)
The role and place of glucocorticosteroids in treatment of COVID-19 pneumonia without hypoxemia
V. V. Salukhov et al.
Meditsinskiy Sovet (2021)
HIGH-DOSE VS LOW-DOSE DEXAMETHASONE IN PATIENTS WITH COVID-19 IN A TERTIARY HOSPITAL IN WESTERN HONDURAS
Eleazar Montalvan et al.
CHEST (2021)
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
Lin T. Brandal et al.
EUROSURVEILLANCE (2021)
Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial
Xiao Tang et al.
RESPIRATION (2021)
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial
Inigo Les Bujanda et al.
TRIALS (2021)
Sex and age differences in COVID-19 mortality in Europe
Linda Juel Ahrenfeldt et al.
WIENER KLINISCHE WOCHENSCHRIFT (2021)
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia The COVID STEROID 2 Randomized Trial
Marie W. Munch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan
Marie Warrer Munch et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2021)
Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial
Abdelrahman Ahmed Abdelalim et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)
Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
Laura Pasin et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)
Methylprednisolone in adults hospitalized with COVID-19 pneumonia An open-label randomized trial (GLUCOCOVID)
Luis Corral-Gudino et al.
WIENER KLINISCHE WOCHENSCHRIFT (2021)
COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India
Jesil Mathew Aranjani et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
Hamidreza Jamaati et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study
Charlotte Thibeault et al.
INFECTION (2021)
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
Dipayan Chaudhuri et al.
INTENSIVE CARE MEDICINE (2021)
Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial
Camila Miriam Suemi Sato Barros et al.
FRONTIERS IN MEDICINE (2021)
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
Rohini Mathur et al.
LANCET (2021)
COVID-19 and disparities affecting ethnic minorities
Daniel R. Morales et al.
LANCET (2021)
Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
Alaa Rashad et al.
SCIENTIFIC REPORTS (2021)
Climate and the spread of COVID-19
Simiao Chen et al.
SCIENTIFIC REPORTS (2021)
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial
Marie Warrer Munch et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2021)
A comparative study of the efficacy and outcome of methylprednisolone and dexamethasone in moderate to severe COVID-19 disease
Praveen B Gautam et al.
Asian Journal of Medical Sciences (2021)
The impact of race and ethnicity on outcomes in 19,584 adults hospitalized with COVID-19
Ann M. Navar et al.
PLOS ONE (2021)
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
Thais G. Moreira et al.
FRONTIERS IN IMMUNOLOGY (2021)
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
Naveen B. Naik et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Ethnicity and acute hospital admissions: Multi-center analysis of routine hospital data
Yize I. Wan et al.
ECLINICALMEDICINE (2021)
The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial
Mostafa Ghanei et al.
RESPIRATORY RESEARCH (2021)
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol
X. Solanich et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2021)
Remdesivir for the treatment of COVID-19
Kelly Ansems et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Colchicine for the treatment of COVID-19
Agata Mikolajewska et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles
Nicole Skoetz et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
Nancy Santesso et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer et al.
ANNALS OF INTERNAL MEDICINE (2020)
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial
Yuan-Yuan Qin et al.
CHINESE MEDICAL JOURNAL (2020)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesus Villar et al.
LANCET RESPIRATORY MEDICINE (2020)
An overview of platform trials with a checklist for clinical readers
Jay J. H. Park et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan
Marie Warrer Petersen et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2020)
Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review
Daniel P. Oran et al.
ANNALS OF INTERNAL MEDICINE (2020)
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping et al.
CELL (2020)
Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study
Pedro Baqui et al.
LANCET GLOBAL HEALTH (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Maryam Edalatifard et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial
Miriam Saiz-Rodriguez et al.
TRIALS (2020)
Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial
Nafiseh Abdolahi et al.
TRIALS (2020)
Embedding a COVID-19 Group Sequential Clinical Trial Within an Ongoing Trial: Lessons From an Unusual Experience
Pierre-Francois Dequin et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Pierre-Francois Dequin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial
Stefano Busani et al.
TRIALS (2020)
High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
Luis Patricio Maskin et al.
TRIALS (2020)
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
Janine Alessi et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
Diana Buitrago-Garcia et al.
PLOS MEDICINE (2020)
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease
Thomas Struyf et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Global Epidemiology of Mucormycosis
Hariprasath Prakash et al.
JOURNAL OF FUNGI (2019)
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
Bram Rochwerg et al.
CRITICAL CARE MEDICINE (2018)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Corticosteroids and Transition to Delirium in Patients With Acute Lung Injury
Matthew P. Schreiber et al.
CRITICAL CARE MEDICINE (2014)
Comorbid Diabetes and COPD Impact of corticosteroid use on diabetes complications
Gillian E. Caughey et al.
DIABETES CARE (2013)
PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
Vivian Welch et al.
PLOS MEDICINE (2012)
Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function
Matthew D. Taves et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
How to handle mortality when investigating length of hospital stay and time to clinical stability
Guy N. Brock et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Immunosenescence: emerging challenges for an ageing population
Danielle Aw et al.
IMMUNOLOGY (2007)
How corticosteroids control inflammation: Quintiles prize lecture 2005
Peter J. Barnes
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)